We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Argonne Contribute 1,000th Structure to Protein Data Bank

The 1,000th deposit provides insight into how cells sense and communicate information.
News

Alberta and Varian Collaborate on Disease Diagnosis Research

Government funds second phase of the Magnetic Resonance Diagnostics Centre at the University of Alberta.
News

A Real Time Look at Interactions Between RNA and Proteins

Researchers study how manipulation of cellular physiology, such as administering a drug, changes RNA-binding protein and RNA interactions.
News

RxP and BioTrove Announce Collaboration

The Companies will provide primate-human transcription and SNP assays for toxicology.
News

Peakdale Completes Peakexplorer™ GPCR Collection for Drug Discovery

The Library has been designed to address gaps in commercially available compound collections.
News

Medistem Reports Method of Immunomodulation

Medistem has developed the method of immune response modification utilizing a genetic reprogramming technology involving RNAi.
News

Medarex Receives Milestone Payment From ImClone

Medarex receives Payment following the acceptance of an IND application for a fully human antibody.
News

Lentigen and Evrogen Enter License Agreement

Lentigen will obtain access to certain fluorescent protein technologies from Evrogen.
News

CytRx Accelerates RNAi Therapeutics Programs

CytRx plans to form a new subsidiary to accelerate the development and commercialization RNAi based drugs.
News

Clinical Data Initiates Phase III Trial for Antidepressant 'Vilazodone'

The outcome of this trial would serve as one of two pivotal trials required for a new drug application.
Advertisement